Phase I study of hexamethylmelamine (NSC-13875).
D000477:Alkylating Agents / Q000008:administration & dosage* / Q000633:toxicity*; D000818:Animals; D004285:Dogs; D005260:Female; D000882:Haplorhini; D006801:Humans; D008297:Male; D051379:Mice; D051381:Rats; D014227:Triazines / Q000008:administration & dosage* / Q000633:toxicity*
D000477:Alkylating Agents; D014227:Triazines